Stefan Gross, Head of Biochemistry at Servier: Driving Innovation in Drug Discovery
Improving the lives of our patients
We work tirelessly to deliver meaningful therapeutics for the patients we serve.
Stefan Gross, Head of Biochemistry at Servier: Driving Innovation in Drug Discovery
Servier Ranked Among Top Companies Across Several Categories in 2024 PatientView Corporate Reputation of Pharma Survey
Servier to Acquire Exclusive Worldwide Rights of BioNova’s BN104, a potential best-in-class menin inhibitor